Thomas Tängdén

4.1k total citations
64 papers, 1.8k citations indexed

About

Thomas Tängdén is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Thomas Tängdén has authored 64 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Medicine, 27 papers in Pharmacology and 19 papers in Epidemiology. Recurrent topics in Thomas Tängdén's work include Antibiotic Resistance in Bacteria (33 papers), Antibiotics Pharmacokinetics and Efficacy (27 papers) and Bacterial Identification and Susceptibility Testing (16 papers). Thomas Tängdén is often cited by papers focused on Antibiotic Resistance in Bacteria (33 papers), Antibiotics Pharmacokinetics and Efficacy (27 papers) and Bacterial Identification and Susceptibility Testing (16 papers). Thomas Tängdén collaborates with scholars based in Sweden, United Kingdom and United States. Thomas Tängdén's co-authors include Christian G. Giske, Otto Cars, Åsa Melhus, Elisabeth Löwdin, Pernilla Lagerbäck, Lena E. Friberg, Elisabet I. Nielsen, Linus Sandegren, Rachel A. Hickman and Pontus Forsberg and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Thomas Tängdén

56 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Tängdén Sweden 22 1.0k 550 516 371 295 64 1.8k
Elizabeth B. Hirsch United States 21 1.2k 1.1× 658 1.2× 578 1.1× 380 1.0× 233 0.8× 68 2.0k
Eric Wenzler United States 24 872 0.8× 636 1.2× 444 0.9× 393 1.1× 254 0.9× 80 1.5k
Demei Zhu China 25 1.3k 1.2× 594 1.1× 633 1.2× 351 0.9× 359 1.2× 65 2.0k
Melanie Baxter Canada 24 841 0.8× 448 0.8× 679 1.3× 291 0.8× 320 1.1× 76 1.6k
Latania K. Logan United States 21 1.6k 1.6× 570 1.0× 651 1.3× 478 1.3× 373 1.3× 66 2.3k
Simona Barnini Italy 25 1.1k 1.0× 509 0.9× 641 1.2× 473 1.3× 492 1.7× 59 1.9k
S. Bouchillon United States 19 882 0.9× 371 0.7× 623 1.2× 292 0.8× 250 0.8× 34 1.4k
Elizabeth Temkin Israel 17 812 0.8× 236 0.4× 405 0.8× 506 1.4× 252 0.9× 57 1.6k
Alyssa Golden Canada 17 879 0.9× 564 1.0× 609 1.2× 265 0.7× 146 0.5× 44 1.6k
Giannoula S. Tansarli United States 24 1.4k 1.4× 828 1.5× 1.0k 2.0× 674 1.8× 422 1.4× 50 2.5k

Countries citing papers authored by Thomas Tängdén

Since Specialization
Citations

This map shows the geographic impact of Thomas Tängdén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Tängdén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Tängdén more than expected).

Fields of papers citing papers by Thomas Tängdén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Tängdén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Tängdén. The network helps show where Thomas Tängdén may publish in the future.

Co-authorship network of co-authors of Thomas Tängdén

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Tängdén. A scholar is included among the top collaborators of Thomas Tängdén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Tängdén. Thomas Tängdén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narayanan, Navaneeth, et al.. (2025). (Val)ganciclovir dosing for cytomegalovirus: revisiting the 2005 Wiltshire et al. pharmacokinetic/pharmacodynamic target. SHILAP Revista de lepidopterología. 3(1). 105171–105171.
2.
Пантели, Димитра, Michael Anderson, Enrico Baraldi, et al.. (2024). Policy options for sustainable access to off-patent antibiotics in Europe. SHILAP Revista de lepidopterología. 2(1). 40–40.
3.
Pandey, Avaneesh Kumar, Jennifer Cohn, Vrinda Nampoothiri, et al.. (2024). A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages. Clinical Microbiology and Infection. 31(3). 345–353. 14 indexed citations
4.
Tängdén, Thomas, et al.. (2023). Therapeutic drug monitoring of vancomycin and meropenem: Illustration of the impact of inaccurate information in dose administration time. International Journal of Antimicrobial Agents. 63(1). 107032–107032. 4 indexed citations
5.
Olsson, Anna, Chenyan Zhao, Lena E. Friberg, et al.. (2023). Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time–kill experiments: agreement with in silico predictions. Journal of Antimicrobial Chemotherapy. 79(2). 391–402. 5 indexed citations
6.
Cojutti, Pier Giorgio, Aaron J. Heffernan, Thomas Tängdén, et al.. (2023). Population Pharmacokinetic and Pharmacodynamic Analysis of Valganciclovir for Optimizing Preemptive Therapy of Cytomegalovirus Infections in Kidney Transplant Recipients. Antimicrobial Agents and Chemotherapy. 67(3). e0166522–e0166522. 5 indexed citations
7.
8.
9.
Lindström, Anna & Thomas Tängdén. (2022). Introducing the C-reactive protein point-of-care test: A conversation analytic study of primary care consultations for respiratory tract infection. Social Science & Medicine. 315. 115493–115493. 5 indexed citations
10.
Kurland, Siri, Elisabeth Löwdin, Mia Furebring, et al.. (2021). Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?. Mycoses. 65(1). 79–87. 3 indexed citations
11.
Zhao, Chenyan, et al.. (2020). Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data. International Journal of Antimicrobial Agents. 55(6). 105941–105941. 15 indexed citations
12.
Tängdén, Thomas, Carina Vingsbo Lundberg, Lena E. Friberg, & Angela Huttner. (2020). How preclinical infection models help define antibiotic doses in the clinic. International Journal of Antimicrobial Agents. 56(2). 106008–106008. 22 indexed citations
13.
Catho, Gaud, Johan W. Mouton, Marlies Hulscher, et al.. (2020). Study protocol for an international, multicentre stepped-wedge cluster randomised trial to evaluate the impact of a digital antimicrobial stewardship smartphone application. BMJ Open. 10(6). e033640–e033640. 5 indexed citations
14.
15.
Huttner, Benedikt, et al.. (2019). Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries: Results of an online survey. International Journal of Antimicrobial Agents. 54(4). 478–486. 37 indexed citations
16.
Tängdén, Thomas, Véronique Martin, Tim Felton, et al.. (2017). The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Intensive Care Medicine. 43(7). 1021–1032. 89 indexed citations
17.
Dittrich, Sabine, Birkneh Tilahun Tadesse, Francis Moussy, et al.. (2017). Target Product Profile for a Diagnostic Assay to Differentiate Between Bacterial and Non-Bacterial Infections to Guide Antimicrobials Use in Resource-Limited Settings: An Expert Consensus. American Journal of Tropical Medicine and Hygiene. 95. 527–527. 1 indexed citations
18.
Tängdén, Thomas, Matti Karvanen, Lena E. Friberg, Inga Odenholt, & Otto Cars. (2017). Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments.. Scandinavian Journal of Infectious Diseases. 1–7. 1 indexed citations
19.
Tängdén, Thomas. (2012). Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae : Treatment, Selection and International Spread. KTH Publication Database DiVA (KTH Royal Institute of Technology). 13(1). 1–10. 2 indexed citations
20.
Tängdén, Thomas. (2008). Foreign Travel a Risk Factor for Colonization with ESBL-Producing Enterobacteriaceae : A Prospective Study on Swedish Travellers. 46th Annual Meeting. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth B. Hirsch Breakdown of academic impact, for papers by Eric Wenzler Breakdown of academic impact, for papers by Demei Zhu Breakdown of academic impact, for papers by Melanie Baxter Breakdown of academic impact, for papers by Latania K. Logan Breakdown of academic impact, for papers by Simona Barnini Breakdown of academic impact, for papers by S. Bouchillon Breakdown of academic impact, for papers by Elizabeth Temkin Breakdown of academic impact, for papers by Alyssa Golden Breakdown of academic impact, for papers by Giannoula S. Tansarli
Rankless by CCL
2026